Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
ENVB
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
finance.yahoo.comPOSITIVO
Enveric Biosciences Reports Financial Results and Provides Corporate Update for First Quarter 2026
Product Development Highlights: Continued advancement of lead candidate EB-003 with IND-enabling studies progressing toward planned first-in-human clinical trial Reported additional preclinical data for EB-003 demonstrating dual Gq and β-a…
Stock market today: S&P 500, Nasdaq, Dow edge lower as US-Iran tensions flare up again, shuttering Hormuz
US stocks fell on Monday after a chaotic weekend of events reignited US-Iran tensions, putting peace talks at risk and leaving investors bracing for more uncertainty. The S&P 500 (^GSPC) shed 0.1%, while the tech-heavy Nasdaq Composite (^I…
Enveric Biosciences targets up to $13.9M in total proceeds via share and warrant offering
Enveric Biosciences (ENVB [https://seekingalpha.com/symbol/ENVB]) has announced its agreement to sell 2.22M shares [https://seekingalpha.com/pr/20477201-enveric-biosciences-announces-up-to-13_9-million-private-placement-priced-at-the-marke…
Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2025
Product Development Highlights: Reported positive preclinical results for lead drug candidate EB-003, showing statistically significant improvements in animal models of severe chronic depression and despair and in post-traumatic stress dis…
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Key Takeaways; Cannabis Sector Organigram Secured C$65.2 Million Strategic Investment from British American Tobacco After the Company Agreed to Acquire Sanity Group Canopy Growth Secured Shareholder Backing for MTL Cannabis Acquisition Gre…
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Key Takeaways; Cannabis Sector Cronos Acquired Europe’s Largest Adult-use Cannabis Company Aurora Introduced a New Proprietary Cultivar to Polish Market Trulieve Redeemed Costly 2026 Senior Secured Notes and Lined Up Fresh $100M Financing…
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Key Takeaways; Cannabis Sector Village Farms Broke New Ground with Vape Launch in Quebec Organigram Announced Former BAT Strategy Chief as New CEO MTL Cannabis Posted Solid Second Quarter Results with Strong Margins and Improved Balance Sh…
AbbVie ends in green six straight sessions of declines
[AbbVie] hapabapa AbbVie (NYSE:ABBV [https://seekingalpha.com/symbol/ABBV]) snapped six consecutive sessions of losses on Thursday as the stock ended 0.29% lower at $226.87. Since October 8, the stock has closed in the red every day until…
AbbVie could face patent battle over depression asset gained in Gilgamesh deal
[Patent infringement] TheaDesign * Microcap Enveric Biosciences (NASDAQ:ENVB [https://seekingalpha.com/symbol/ENVB]) is threatening to take legal action against AbbVie (NYSE:ABBV [https://seekingalpha.com/symbol/ABBV]) as it believes that…
Enveric Biosciences hires Fish & Richardson to defend patent tied to AbbVie deal
Investing.com -- Enveric Biosciences (NASDAQ: ENVB) has hired prominent intellectual property law firm Fish and Richardson P.C. to contest a Post-Grant Review (PGR) petition filed by Gilgamesh Pharmaceuticals, which earlier this year agree…
Enveric Biosciences Hires IP Powerhouse to Defend Its U.S. Patent with Claims Relevant to Bretisilocin, Recently Acquired by AbbVie in $1.2 Billion Deal
EB-003, Enveric’s lead product candidate, is protected by a different patent family that includes an issued U.S. patent and pending U.S. and international patents, all of which are separate and distinct from the patent that appears relevan…
Enveric Biosciences Gets FDA Response On Request For Pre-IND Type B Meeting For Lead Program EB-003
(RTTNews) - Biotechnology company Enveric Biosciences, Inc. (ENVB) announced Tuesday that it has received a written response from the U.S. Food and Drug Administration (FDA) to its request for a Pre-Investigational New Drug (pre-IND) Type…
Enveric Biosciences receives second patent allowance for PTSD drug
CAMBRIDGE, Mass. - Enveric Biosciences (NASDAQ:ENVB) announced Wednesday it has received a second Notice of Allowance from the United States Patent and Trademark Office for compounds in its EVM401 Series, expanding its intellectual propert…
Enveric's lead drug candidate shows additional receptor activity
CAMBRIDGE, Mass. - Enveric Biosciences (NASDAQ:ENVB), a biotechnology company currently trading at $1.25 per share and showing signs of being undervalued according to InvestingPro Fair Value metrics, announced Tuesday that its lead drug ca…
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Key Takeaways; Cannabis Sector Scotts Miracle-Gro will finally separate its cannabis arm, Hawthorne, into a stand-alone cannabis business High Tide narrowed losses in 2024 amid record revenue and expansion plans Key Takeaways; Psychedelic…
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Key Takeaways; Cannabis Sector Ayr Wellness reported solid first quarter results. Cresco Labs reported stagnant sales but an optimistic outlook for 2024. Tilray announced a $250 million equity offering to fund U.S. asset acquisitions amid…
Diamond Equity Research Initiates Coverage on Enveric Biosciences Inc. (NASDAQ: ENVB)
NEW YORK, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has initiated coverage of Enveric Biosciences Inc. (NASDAQ: ENVB). The in-depth 23-pa…
10 Most Promising Psychedelic Stocks According To Analysts
In this article, we discuss 10 most promising psychedelic stocks according to analysts. If you want to see more stocks in this selection, check out 5 Most Promising Psychedelic Stocks According To Analysts. Psychedelic drugs encompass a ra…
The 7 Most Promising Psychedelic Stocks to Buy in February
Psychedelic stocks have seen remarkable progress in recent years, evolving from a fad to mainstream medicine. Several pharmaceutical companies are now investigating their potential therapeutic value. They’re also following regulatory pathw…
Main Street Can Ride Short-Term Vacation Rental Trend With reAlpha’s Share Offering
reAlpha to capitalize on booming short-term rental market driven by Airbnb, Inc. Any investor can invest via Reg A share offeringof up to $75 million through Dec. 8 Short-term rental market has gigantic $1.2 trillion total addressable mark…
Psychedelics stocks are becoming increasingly mainstream, in part due to changing social attitudes. Psychedelic drugs “are a loosely grouped class of drugs that are able to induce altered thoughts and sensory perceptions.” Recent medical r…
7 Short-Squeeze Stocks to Put on Your Must-Watch List
The beaten-down stock market has created an opportunity for contrarian investors in short-squeeze stocks. Essentially, bearish traders must borrow the underlying securities which they are pessimistic about. However, bullish traders en mass…
Key Takeaways: Trulieve, TerrAscend, and Verano Holdings amongst Top Cannabis Gainers for the Week. Awakn Findings from Phase II A/B KARE Study to Be Published In American Journal of Psychiatry; Awakn to Participate at the Wonderland: Miam…
Investor Summit Group Provides Update on Upcoming Q4 Virtual Summit
NEW YORK, Nov. 05, 2021 (GLOBE NEWSWIRE) -- The Investor Summit Group, widely recognized for its reputation as the host of North America’s largest independent investor conferences, will be hosting the upcoming Q4 Virtual Summit on November…
KCSA Psychedelics Virtual Investor Conference Presentations Available for On-Demand Viewing
Individual and institutional investors as well as advisors are invited to log-on to VirtualInvestorConferences.com to view presentations NEW YORK, Oct. 18, 2021 /PRNewswire/ -- Virtual Investor Conferences in partnership with KCSA Strategi…
KCSA Psychedelics Virtual Investor Conference Agenda Announced for October 13th & 14th
Psychedelic and CNS Company Executives share vision, answer questions live at VirtualInvestorConferences.com NEW YORK, Oct. 11, 2021 /CNW/ - Virtual Investor Conferences in partnership with KCSA Strategic Communications today announced the…
Proactive news headlines including Thesis Gold, IEC Electronics, Tetra Bio-Pharma and Mydecine
New York, Oct. 05, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies: Tetra Bio-Pharma (TSX:TBP, OTCQB:TBPMF) says its f…
Gainers Superior Drilling Products, Inc. (NYSE: SDPI) rose 58.7% to $1.73 in pre-market trading after jumping over 23% on Wednesday. The company, last month, reported Q2 earnings of $0.00 per share on sales of $3.40 million. Farmmi, Inc. (…
Psyched: First Active Psychedelics ETF Hits NYSE, Compass Dives Into Novel Molecules, Atai Subsidiary Launches Phase 2a Trial
AdvisorShares Launches First NYSE-listed Actively-managed Psychedelics ETF On Thursday, AdvisorShares launched the country’s first actively managed ETF covering the psychedelics sector. The AdvisorShares Psychedelics ETF (NYSE: PSIL), laun…
Gainers Rocket Lab USA, Inc. (NASDAQ: RKLB) jumped 37.3% to settle at $20.72. Rocket Lab reported 1H sales of $29.5 million and announced it has been awarded a contract to deploy an entire satellite constellation for Kinéis. Canaccord Genu…
Gainers IronNet, Inc. (NYSE: IRNT) rose 89.7% to $31.61 in pre-market trading after jumping over 23% on Friday. Mechel PAO (NYSE: MTL) shares rose 36.6% to $4.37 in pre-market trading. The company recently reported Q2 results, including a…
Gainers Cellect Biotechnology Ltd. (NASDAQ: APOP) shares jumped 35% to $7.43. Cellect Biotechnology announced the first ApoGraft transplantation in a Leukemia patient in a clinical trial in the U.S. ApoGraft is designed to prevent graft-ve…
Gainers Cellect Biotechnology Ltd. (NASDAQ: APOP) rose 59.5% to $8.77 in pre-market trading after the company announced the ApoGraft bone marrow transplantation of the first patient in the US. Advaxis, Inc. (NASDAQ: ADXS) shares rose 14.7%…
Psyched: GH Research Debuts on Nasdaq, Compass Reaches Psilocybin Research Milestone, Maxim Gives BUY Rating to 10 Psychedelics Companies
Irish 5-MeO-DMT Company GH Research Debuts On Nasdaq GH Research, a Dublin-based company studying the potential of 5-MeO-DMT for the treatment of psychiatric and neurological disorders, is now listing its stock on the Nasdaq under the symb…
SHAREHOLDER ALERT: Halper Sadeh LLP Investigates ARPO, ALTA, ENVB, FBNC, MCF; Shareholders are Encouraged to Contact the Firm
NEW YORK, June 28, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: (PRNewsfoto/Halper Sadeh LLP) Aerpio Pharmaceuticals, Inc. (NASDAQ: ARPO) concerning potent…